Dr. Reddy’s Recalls Levetiracetam Injection in the U.S. Due to Mislabeled Infusion Bags

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “D...

March 14, 2025 | Friday | News
Enzene India Secures EU GMP Certification for Pune Facilities, Strengthening Global Biologics Manufacturing

Enzene, a pioneer in fully-connected continuous biologics manufacturing technology, today announced that its two facilities in Pune have received Europea...

March 05, 2025 | Wednesday | News
Miltenyi Biotec Expands Global Footprint with New Cell & Gene Therapy Center in India’s Genome Valley

  Miltenyi Biotec, a global leader in cell and gene therapy solutions, has inaugurated a cutting-edge Cell & Gene Therapy Center in Genome Valley...

February 25, 2025 | Tuesday | News
Swiss Business Hub India Strengthens Swiss-Indian Ties at World Economic Forum 2025 in Davos

The Swiss Business Hub India once again played a pivotal role at the sidelines of the World Economic Forum 2025 in Davos, fostering connections between s...

January 27, 2025 | Monday | News
ReciBioPharm Secures Gates Foundation Grant to Advance RNA Manufacturing Technologies for Global Health

3-year grant received from the Bill & Melinda Gates Foundation to enhance RNA production technologies Grant enables global implementation of the ...

January 21, 2025 | Tuesday | News
CG MedTech Partners with CGBIO to Host International Spine Endoscopy Training, Highlighting Korea’s Leadership in Minimally Invasive Surgery

CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered with CGBIO&nb...

January 01, 2025 | Wednesday | News
India Exempts Gene Therapy from Goods and Services Tax, Setting a Global Healthcare Benchmark

  India’s 55th GST Council meeting, chaired by Union Finance Minister Nirmala Sitharaman, announced a complete exemption of Goods and Services ...

December 25, 2024 | Wednesday | News
Driving the Future of Biopharma in 2025: How MoleculeAI is Shaping AI-Driven Drug Discovery

  In an interaction with BioPharma BoardRoom, Saurabh Singal, CEO & Founder of MoleculeAI, discusses how their generative AI-driven tools...

December 19, 2024 | Thursday | Interview
Valneva and Serum Institute of India Partner to Deliver Asia’s First Single-Shot Chikungunya Vaccine

  Valneva SE (“Valneva” or “the Company”), a specialty vaccine company, and Serum Institute of India (SII), the world’s...

December 19, 2024 | Thursday | News
Accropeutics' RIPK2 Inhibitor AC-101 Receives FDA Clearance for Phase II Trial in Ulcerative Colitis

Accropeutics Inc. (Accropeutics), a clinical-stage biotech company with a focus on molecular mechanisms of regulated cell death and related pathogenesis in...

December 16, 2024 | Monday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
Enzene Launches Advanced EnzeneX™ 2.0 Platform at CPHI Milan

Enzene, a fully integrated CDMO with services spanning discovery, development and commercial supply, today announced it is to launch its new EnzeneX&trad...

October 07, 2024 | Monday | News
Eli Lilly CEO David Ricks Announces Major Expansion of India Research Hub, Poised to Transform Global Drug Innovation

Eli Lilly and Company (NYSE: LLY), a global leader in biopharmaceuticals, has announced plans to expand its research and development (R&D) center in ...

September 24, 2024 | Tuesday | News
Panacea Biotec Secures $20 Million from U.S. DFC to Scale Up World’s First Fully-Liquid Hexavalent Vaccine

Panacea Biotec, a leading global biopharmaceutical company, is thrilled to announce a new milestone in its mission to protect children from life-threaten...

September 12, 2024 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close